Observed responses in research settings are generally mild and may include temporary administration-site irritation, redness, warmth sensations, local sensitivity, temporary itching, mild fatigue, or response variability depending on research amount, administration frequency, protocol duration, and individual sensitivity
Forget one-size-fits-all
[6] At present, NAD+ Injection has no well-defined absolute contraindications aside from hypersensitivity to NAD+ or any ingredient in the formulation
GHK-Cu is considered to be very safe but there are always a few side effects related to any substance that is taken for health
Yoshida, et al ., 1995], concerning the mesoscopic d properties of aqueous solutions next to surfaces [Chai et al ., 2008
Sikiric has since published more than 150 papers on BPC-157